IPO
Lisata Therapeutics' Tender Offer: What It Means for Investors
Kuva Labs proposes a tender offer for Lisata Therapeutics, potentially valuing shares at $7.00 each. What does this mean for investors?
Marcus Rivera • June 10, 2026
Technology
Palantir's Position in the AI Landscape: Challenges and Opportunities Ahead
Palantir's CEO Alex Karp highlights the dissatisfaction businesses face with frontier AI labs, impacting Palantir's mark…
Sarah Chen • Jun 10
Markets
Amazon's Logistics Expansion: A Game Changer for Freight Stocks?
Amazon's logistics push is reshaping the freight landscape, threatening established trucking firms and presenting new op…
James McAllister • Jun 10
Technology
Figure Technology Strengthens Blockchain Presence with Kiavi Acquisition
Figure Technology is set to enhance its blockchain marketplace through the acquisition of Kiavi.
Tyler Brooks • Jun 10
Free Newsletter
Informed positions start with informed mornings.
Market-moving analysis and institutional-grade research, complimentary and delivered daily.
More Stories
Markets
Oracle's Bullish Options Activity Signals Potential Market Movement
Diana Kowalski • Jun 10, 2026
Analysis
Ingredion's All-Cash Acquisition of Tate & Lyle: Implications for the Food Industry
Marcus Rivera • Jun 10, 2026
Markets
APA Corporation's Strategic Move in Alaska: A New Chapter in Energy Operations
James McAllister • Jun 10, 2026
Analysis
Cycurion's Strategic Acquisition: Enhancing AI-Driven Cybersecurity Solutions
Marcus Rivera • Jun 9, 2026
